Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Driveline infections in patients supported with a HeartMate II: incidence, aetiology and outcome.

Bomholt T, Moser C, Sander K, Boesgaard S, Køber L, Olsen PS, Hansen PB, Mortensen SA, Gustafsson F.

Scand Cardiovasc J. 2011 Oct;45(5):273-8. doi: 10.3109/14017431.2011.577236. Epub 2011 May 4.

PMID:
21539474
2.

The Jarvik 2000 is associated with less infections than the HeartMate left ventricular assist device.

Siegenthaler MP, Martin J, Pernice K, Doenst T, Sorg S, Trummer G, Friesewinkel O, Beyersdorf F.

Eur J Cardiothorac Surg. 2003 May;23(5):748-54; discussion 754-5.

PMID:
12754028
3.

Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.

Stulak JM, Davis ME, Haglund N, Dunlay S, Cowger J, Shah P, Pagani FD, Aaronson KD, Maltais S.

J Thorac Cardiovasc Surg. 2016 Jan;151(1):177-89. doi: 10.1016/j.jtcvs.2015.09.100. Epub 2015 Nov 4.

PMID:
26545967
4.

Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.

Kormos RL, Teuteberg JJ, Pagani FD, Russell SD, John R, Miller LW, Massey T, Milano CA, Moazami N, Sundareswaran KS, Farrar DJ; HeartMate II Clinical Investigators.

J Thorac Cardiovasc Surg. 2010 May;139(5):1316-24. doi: 10.1016/j.jtcvs.2009.11.020. Epub 2010 Feb 4.

5.

Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.

John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L.

Ann Thorac Surg. 2008 Oct;86(4):1227-34; discussion 1234-5. doi: 10.1016/j.athoracsur.2008.06.030.

PMID:
18805167
6.

Prospective, multicenter study of ventricular assist device infections.

Gordon RJ, Weinberg AD, Pagani FD, Slaughter MS, Pappas PS, Naka Y, Goldstein DJ, Dembitsky WP, Giacalone JC, Ferrante J, Ascheim DD, Moskowitz AJ, Rose EA, Gelijns AC, Lowy FD; Ventricular Assist Device Infection Study Group.

Circulation. 2013 Feb 12;127(6):691-702. doi: 10.1161/CIRCULATIONAHA.112.128132. Epub 2013 Jan 11.

7.

Double tunnel technique for the LVAD driveline: improved management regarding driveline infections.

Schibilsky D, Benk C, Haller C, Berchtold-Herz M, Siepe M, Beyersdorf F, Schlensak C.

J Artif Organs. 2012 Mar;15(1):44-8. doi: 10.1007/s10047-011-0607-3. Epub 2011 Oct 11.

PMID:
21987183
8.

Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.

Topkara VK, Kondareddy S, Malik F, Wang IW, Mann DL, Ewald GA, Moazami N.

Ann Thorac Surg. 2010 Oct;90(4):1270-7. doi: 10.1016/j.athoracsur.2010.04.093.

PMID:
20868826
9.

Prevention of percutaneous driveline infection after left ventricular assist device implantation: prophylactic antibiotics are not necessary.

Stulak JM, Maltais S, Cowger J, Joyce LD, Daly RC, Park SJ, Aaronson KD, Pagani FD.

ASAIO J. 2013 Nov-Dec;59(6):570-4. doi: 10.1097/MAT.0b013e3182a9e2a5.

PMID:
24172262
10.

A matched prospective cohort study on Staphylococcus aureus and Escherichia coli bloodstream infections: extended perspectives beyond resistance.

Berger J, Diab-Elschahawi M, Blacky A, Pernicka E, Spertini V, Assadian O, Koller W, Aichberger KJ.

Am J Infect Control. 2010 Dec;38(10):839-45. doi: 10.1016/j.ajic.2010.04.212. Epub 2010 Jul 22.

PMID:
20650546
11.

Left ventricular assist device driveline infections.

Pereda D, Conte JV.

Cardiol Clin. 2011 Nov;29(4):515-27. doi: 10.1016/j.ccl.2011.08.004.

PMID:
22062200
12.

Reduction in driveline infection rates: Results from the HeartMate II Multicenter Driveline Silicone Skin Interface (SSI) Registry.

Dean D, Kallel F, Ewald GA, Tatooles A, Sheridan BC, Brewer RJ, Caldeira C, Farrar DJ, Akhter SA; SSI Registry Investigators.

J Heart Lung Transplant. 2015 Jun;34(6):781-9. doi: 10.1016/j.healun.2014.11.021. Epub 2014 Dec 5.

PMID:
25735901
13.

Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support.

Zierer A, Melby SJ, Voeller RK, Guthrie TJ, Ewald GA, Shelton K, Pasque MK, Moon MR, Damiano RJ Jr, Moazami N.

Ann Thorac Surg. 2007 Aug;84(2):515-20.

PMID:
17643627
14.

Role of biofilm in Staphylococcus aureus and Staphylococcus epidermidis ventricular assist device driveline infections.

Toba FA, Akashi H, Arrecubieta C, Lowy FD.

J Thorac Cardiovasc Surg. 2011 May;141(5):1259-64. doi: 10.1016/j.jtcvs.2010.07.016. Epub 2010 Aug 14.

15.

A simple device to secure ventricular assist device driveline and prevent exit-site infection.

Baronetto A, Centofanti P, Attisani M, Ricci D, Mussa B, Devotini R, Simonato E, Rinaldi M.

Interact Cardiovasc Thorac Surg. 2014 Apr;18(4):415-7. doi: 10.1093/icvts/ivt549. Epub 2014 Jan 14.

16.

Age and preoperative total bilirubin level can stratify prognosis after extracorporeal pulsatile left ventricular assist device implantation.

Shiga T, Kinugawa K, Hatano M, Yao A, Nishimura T, Endo M, Kato N, Hirata Y, Kyo S, Ono M, Nagai R.

Circ J. 2011;75(1):121-8. Epub 2010 Nov 23.

17.

Driveline infections in left ventricular assist devices: implications for destination therapy.

Sharma V, Deo SV, Stulak JM, Durham LA 3rd, Daly RC, Park SJ, Baddour LM, Mehra K, Joyce LD.

Ann Thorac Surg. 2012 Nov;94(5):1381-6. doi: 10.1016/j.athoracsur.2012.05.074. Epub 2012 Jul 20.

PMID:
22818961
18.

Clinical manifestations and management of left ventricular assist device-associated infections.

Nienaber JJ, Kusne S, Riaz T, Walker RC, Baddour LM, Wright AJ, Park SJ, Vikram HR, Keating MR, Arabia FA, Lahr BD, Sohail MR; Mayo Cardiovascular Infections Study Group.

Clin Infect Dis. 2013 Nov;57(10):1438-48. doi: 10.1093/cid/cit536. Epub 2013 Aug 13.

19.

Temporal leukocyte numbers and granulocyte activation in pulsatile and rotary ventricular assist device patients.

Woolley JR, Teuteberg JJ, Bermudez CA, Bhama JK, Lockard KL, Kormos RL, Wagner WR.

Artif Organs. 2014 Jun;38(6):447-55. doi: 10.1111/aor.12200. Epub 2013 Oct 29.

20.

SdrF, a Staphylococcus epidermidis surface protein, contributes to the initiation of ventricular assist device driveline-related infections.

Arrecubieta C, Toba FA, von Bayern M, Akashi H, Deng MC, Naka Y, Lowy FD.

PLoS Pathog. 2009 May;5(5):e1000411. doi: 10.1371/journal.ppat.1000411. Epub 2009 May 1.

Items per page

Supplemental Content

Write to the Help Desk